Goreisan

DRUG3 trials

Sponsors

Nagasaki University, Nagasaki University, Takeshi Morimoto

Conditions

Clinical TrialEdemaGlossodyniaHeart FailureKampo MedicineTraditional Japanese Medicine

Phase 4

GOREISAN for Heart Failure (GOREISAN-HF) Trial

Active, not recruitingNCT04691700

Takeshi MorimotoClinical Trial, Edema, Heart Failure +2

Start: 2021-01-19End: 2027-12-31Updated: 2026-01-06

Unknown Phase

The effects of Goreisan on pain perception in Glossodynia associate with dry mouth

Active, not recruitingJPRN-UMIN000035965

Nagasaki UniversityGlossodynia

Start: 2019-02-20Target: 15Updated: 2026-06-29

Examination of the pain relief effect of Goreisan for glossodynia with dry mouth 2

Active, not recruitingJPRN-UMIN000037705

Nagasaki UniversityGlossodynia

Start: 2019-09-01Target: 15Updated: 2026-06-29

Related Papers

Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial.

2023-02-2415 citations